Period of time： 2007年4期
Publisher： VSP
Founded in： 1991
Total resources： 26
ISSN： 1568-5608
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Inflammopharmacology,volume 13,issue 4
Menu
Introduction The coxib controversies
Inflammopharmacology,volume 13,issue 4 , Vol. 13, Iss. 4, 2005-09 , pp.
Access to resources
Recommend
The use of NSAIDs in rheumatic disorders 2005: a global perspective
By Kean Walter F.,Buchanan W. Watson in (2005)
Inflammopharmacology,volume 13,issue 4 , Vol. 13, Iss. 4, 2005-09 , pp.The murky waters of the coxibs: a review of the current state of play
By Ostor Andrew J.K.,Hazleman Brian L. in (2005)
Inflammopharmacology,volume 13,issue 4 , Vol. 13, Iss. 4, 2005-09 , pp.The murky world of the COX-2-selective agents
Inflammopharmacology,volume 13,issue 4 , Vol. 13, Iss. 4, 2005-09 , pp.COX-2 controversy: where are we and where do we go from here?
Inflammopharmacology,volume 13,issue 4 , Vol. 13, Iss. 4, 2005-09 , pp.Coxibs and their aftermath: an (opinionated) commentary, based on some historical viewpoints
Inflammopharmacology,volume 13,issue 4 , Vol. 13, Iss. 4, 2005-09 , pp.COX-2 inhibitors: a story of greed, deception and death
By Halpern Georges M. in (2005)
Inflammopharmacology,volume 13,issue 4 , Vol. 13, Iss. 4, 2005-09 , pp.